NCT02988960 2026-01-09A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid TumorsAbbViePhase 1 Active not recruiting163 enrolled
NCT03071757 2022-04-28A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid TumorsAbbViePhase 1 Completed139 enrolled